Evolution AB remains a Strong Buy due to its low valuation, high returns on capital, solid growth, and robust free cash flow despite recent headwinds. Q3 challenges included a strike in Georgia, ...
During Machine Design’s medical devices takeover week (Feb. 24-March 2, 2025), contributors were asked to submit content pertaining only to this niche. The rush of content—ranging from articles, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback